Fabtech Cleanrooms Ltd
Incorporated in 2015, Fabtech Technologies Cleanrooms Limited is a global company specializing in turnkey engineering solutions for the pharmaceutical, biotech, and healthcare sectors.[1]
- Market Cap ₹ 553 Cr.
- Current Price ₹ 449
- High / Low ₹ 500 / 203
- Stock P/E 36.7
- Book Value ₹ 84.1
- Dividend Yield 0.45 %
- ROCE 19.4 %
- ROE 15.2 %
- Face Value ₹ 10.0
Pros
- Company has delivered good profit growth of 82.7% CAGR over last 5 years
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Industrials Capital Goods Industrial Manufacturing Industrial Products
Half Yearly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| 89 | 70 | 114 | 125 | 97 | 150 | 219 | |
| 83 | 69 | 107 | 112 | 89 | 134 | 197 | |
| Operating Profit | 6 | 1 | 6 | 13 | 9 | 16 | 22 |
| OPM % | 7% | 2.1% | 5% | 10% | 9% | 11% | 10% |
| 1 | 0 | 0 | 0 | 1 | 1 | 2 | |
| Interest | 1 | 0 | 1 | 1 | 1 | 1 | 2 |
| Depreciation | 1 | 1 | 1 | 1 | 0 | 1 | 2 |
| Profit before tax | 6 | 1 | 5 | 12 | 8 | 16 | 21 |
| Tax % | 28% | -42% | 29% | 31% | 25% | 24% | 20% |
| 4 | 1 | 4 | 8 | 6 | 13 | 17 | |
| EPS in Rs | 1,333.33 | 250.00 | 12.92 | 28.57 | 20.75 | 10.80 | 12.84 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 19% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 26% |
| 3 Years: | 21% |
| TTM: | 46% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 83% |
| 3 Years: | 24% |
| TTM: | 14% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | 9% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 15% |
| 3 Years: | 15% |
| Last Year: | 15% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Equity Capital | 0.03 | 0.03 | 3 | 3 | 3 | 12 | 12 |
| Reserves | 31 | 32 | 35 | 43 | 49 | 82 | 91 |
| 10 | 7 | 8 | 6 | 6 | 1 | 19 | |
| 26 | 30 | 36 | 29 | 32 | 28 | 63 | |
| Total Liabilities | 67 | 69 | 82 | 81 | 89 | 124 | 186 |
| 4 | 5 | 4 | 4 | 5 | 4 | 8 | |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| Investments | 0 | 0 | 0 | 0 | 1 | 27 | 10 |
| 63 | 64 | 77 | 76 | 83 | 93 | 168 | |
| Total Assets | 67 | 69 | 82 | 81 | 89 | 124 | 186 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| -9 | 4 | 3 | 8 | 3 | 3 | -17 | |
| 2 | -1 | -4 | -3 | -2 | -26 | 1 | |
| 7 | -3 | 1 | -4 | -1 | 24 | 14 | |
| Net Cash Flow | 1 | -0 | -0 | 1 | 0 | 1 | -2 |
| Free Cash Flow | -12 | 3 | 2 | 8 | 1 | 0 | -27 |
| CFO/OP | -115% | 292% | 52% | 80% | 71% | 41% | -71% |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Debtor Days | 181 | 221 | 165 | 144 | 193 | 129 | 146 |
| Inventory Days | 63 | 95 | 63 | 57 | 88 | 67 | 81 |
| Days Payable | 114 | 146 | 105 | 82 | 122 | 74 | 85 |
| Cash Conversion Cycle | 130 | 170 | 123 | 119 | 159 | 122 | 142 |
| Working Capital Days | 112 | 144 | 92 | 95 | 140 | 124 | 111 |
| ROCE % | 2% | 14% | 26% | 16% | 21% | 19% |
Insights
In beta| Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|
| Number of Manufacturing Facilities count |
|
||
| Order Book (Consolidated) INR Cr |
|||
| Order Pipeline INR Cr |
|||
| Team Size (Employees) count ・Standalone data |
|||
| Order Book - Data Center INR Cr |
|||
| Order Book - Pharma INR Cr |
|||
| Order Book - Solar / Renewable Energy INR Cr |
|||
Extracted by Screener AI
Documents
Announcements
-
Announcement On Order Booking And Update
- August 2026 orders of ₹5.39 crore; order book at ₹469.28 crore, active bids ₹440.05 crore.
-
Submission Of Certificate From Statutory Auditor As per Regulation 169(5) Of The SEBI (Issue Of Capital And Disclosure Requirements) Regulations, 2018 ('ICDR Regulations')
- Auditor certified receipt of Rs15 crore for 3,80,711 convertible warrants at Rs394 each.
-
Disclosure Under Regulation 29(2) Of The SEBI (Substantial Acquisition Of Shares And Takeovers) Regulations, 2011.
- Promoters disclosed acquisition of 3,80,711 warrants at ₹394 each on September 4, 2026.
-
Reg. 34 (1) Annual Report.
- FY26 annual report filed; 11th AGM on September 28, 2026, with related-party transactions up to ₹125 crore.
-
Announcement under Regulation 30 (LODR)-Allotment
- Committee allotted 3,80,711 warrants on September 4, 2026; received ₹3.75 crore upfront.
Concalls
-
Jun 2026TranscriptAI SummaryPPT
-
May 2026Transcript PPT
-
Nov 2025Transcript PPT
-
Jun 2025TranscriptPPT
-
Mar 2025TranscriptAI SummaryPPT
-
Feb 2025TranscriptAI SummaryPPT
Business Overview[1]
Fabtech Technologies Cleanrooms specializes in manufacturing and providing end-to-end solutions for pre-engineered and pre-fabricated modular panels and doors for cleanrooms. These cleanrooms are used in pharmaceutical, healthcare, and biotech sectors and adhere to global regulatory standards like ISO and FDA. The company offers services including design, engineering, manufacturing, quality assurance, installation, and validation.